MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Federal R&D (Research and Development)_NOFO_PAR, PA, PAS, RFA, RFP, Grant, BAA, Cooperative Agreements (CAs)
2023: DOD_CDMRP_FY23 Peer Reviewed Medical Research Program (PRMRP)
Influenza
Parents
2023: DOD_CDMRP_FY23 Peer Reviewed Medical Research Program (PRMRP)
2026: Infectious disease expert reveals viruses to worry about as 'super flu' overwhelms US... including one that could put the world 'on cusp of a pandemic'
Infectious Disease
Children
*Architects: Infectious Disease _ Influenza_Avian Flu, H1N1, H5N1, H5N2
*Developer of influenza vaccines.
*Funding: Infectious Disease _ Influenza (Avian Flu, H1N1, H5N1, H5N2)
*Funding: Pandemic, Outbreak & Epidemic Resiliency_[Coronavirus, Covid-19, SARS-CoV-2, H5N1 Avian Influenza,Mpox]
$50,000 for Novel Anti-Viral Agents to Treat Influenza (2011)
2005: Influenza Pandemic-WHO Guidelines
2005: Responding to the Avian Influenza Pandemic Threat-WHO
2012: BARDA_Advanced Development of Medical Countermeasures for Pandemic Influenza
2014: BARDA_Sources Sought Notice for Universal Influenza Vaccines
2017: Request for Information (RFI): Prospective Longitudinal Cohort Studies of Influenza Infection and Vaccine Effectiveness
2018: CDC_Attenuated influenza vaccine (LAIV)
2019-2020: HHS_ Influenza Virus Vaccine
2021: A single-use, digital fluorescent immunoassay antigen test for SARS-CoV-2 and influenza A/B all-in-one platform. Results are returned in 15 minutes or less. The platform is paired with a mobile app for ease of use and is intended for use in point-of-care settings.
2021: NIAID_Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed)
2021: NIAID_Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)
2021: NIAID_Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed)
2022: Arcturus touts $63M BARDA award for new mRNA influenza vaccine, hoping to prep against future pandemics
2022: Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
2023: CDC_Programmatic Interventions to Increase Uptake of Influenza and COVID-19 Vaccination Among Students Attending Institutions of Higher Education
2024: BARDA_Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
2024: Features of H5N1 influenza viruses in dairy cows may facilitate infection, transmission in mammals
2024: High H5N1 influenza levels found in mice given raw milk from infected dairy cows
2024: U.S. Government Awards BioCryst $69 Million RAPIVAB®
2025: NIAID_NOIP_Advancing Research Needed to Develop a Universal Influenza Vaccine
2026: F.D.A. Approves Moderna’s mRNA Flu Vaccine
Detect
Ellume
H5N1: Avian or Bird Flu_Influenza
Influenza Pandemic-GAO Report
Influenza Pandemics
Influenza vaccine
Luminostics, Inc., dba Clip Health
LumiraDx (LMDX)
MIDAS Influenza Project
Princeton BioMeditech
Topic 11. Understanding carriage of Influenza